Company Description
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America.
The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.
The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions.
It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne.
The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016.
STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Country | United States |
Founded | 1989 |
IPO Date | Oct 28, 2005 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 99 |
CEO | Dr. Dolev Rafaeli Ph.D. |
Contact Details
Address: 5 Walnut Grove Drive, Suite 140 Horsham, Pennsylvania 19044 United States | |
Phone | 215-619-3200 |
Website | strataskinsciences.com |
Stock Details
Ticker Symbol | SSKN |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001051514 |
CUSIP Number | 86272A206 |
ISIN Number | US86272A2069 |
Employer ID | 13-3986004 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Dr. Dolev Rafaeli Ph.D. | President, Chief Executive Officer and Vice-Chairman |
Christopher Lesovitz | Chief Financial Officer |
Shmuel Gov | Chief Operating Officer |
Jay Sturm | General Counsel and Corporate Secretary |
Michael E. Goodman | Head of International Sales |
Michael R. Stewart | Independent Consultant |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jul 18, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Jul 17, 2024 | 8-K | Current Report |
Jul 11, 2024 | 8-K | Current Report |
Jun 25, 2024 | 8-K | Current Report |
Jun 24, 2024 | 424B5 | Filing |
Jun 4, 2024 | 8-K | Current Report |
May 15, 2024 | 10-Q | Quarterly Report |
May 15, 2024 | 8-K | Current Report |
Apr 29, 2024 | 10-K/A | [Amend] Annual report |
Apr 26, 2024 | 8-K | Current Report |